Open access · CC-BY
via OpenAlex
Fisetin as a nutritional senotherapeutic: mechanisms, translational promise, and lessons from chronic kidney disease
Nur Warda B. Mohammed, David P. Baird, Eoin Daniel O'Sullivan
Frontiers in Nutrition · 2026
Abstract
Fisetin is a dietary flavonol that has attracted growing interest as a potential modulator of aging biology. In addition to its antioxidant and anti-inflammatory properties, experimental studies suggest that fisetin may influence cellular senescence(definition) through senomorphic and, in some contexts, senolytic actions. This has made it an attractive candidate within the wider field of food derived functional ingredients that target age related disease. Chronic kidney disease provides a useful case study for this emerging area because it is characterized by accelerated biological aging, chronic inflammation and fibrosis, and is associated with a high burden of frailty and multimorbidity. In this mini review, we summarize the nutritional and pharmacological features of fisetin, examine its proposed mechanisms of action, and discuss preclinical and early clinical evidence with a particular focus on kidney disease. We argue that fisetin is a promising but still unproven nutritional senotherapeutic. Its translation is limited by uncertainty around dietary exposure vs. pharmacological dosing, incomplete mechanistic understanding in vivo , bioavailability constraints, and sparse kidney specific clinical data. Chronic kidney disease highlights both the appeal and the difficulty of applying food derived bioactives to complex age-related disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fnut.2026.1867121
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Mohammed, N.W.B., Baird, D.P., & O'Sullivan, E.D. (2026). Fisetin as a nutritional senotherapeutic: mechanisms, translational promise, and lessons from chronic kidney disease. <em>Frontiers in Nutrition</em>. https://doi.org/10.3389/fnut.2026.1867121
Vancouver
Mohammed NWB, Baird DP, O'Sullivan ED. Fisetin as a nutritional senotherapeutic: mechanisms, translational promise, and lessons from chronic kidney disease. Frontiers in Nutrition. 2026. doi:10.3389/fnut.2026.1867121.
BibTeX
@article{nur2026Fiseti,
title = {Fisetin as a nutritional senotherapeutic: mechanisms, translational promise, and lessons from chronic kidney disease},
author = {Nur Warda B. Mohammed and David P. Baird and Eoin Daniel O'Sullivan},
journal = {Frontiers in Nutrition},
year = {2026},
doi = {10.3389/fnut.2026.1867121},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in nutrition 2026
Citation only
Fisetin as a nutritional senotherapeutic: mechanisms, translational promise, and lessons from chronic kidney disease.
Frontiers in nutrition
Open access · OA
Fisetin as a nutritional senotherapeutic: mechanisms, translational promise, and lessons from chronic kidney disease
Journal of Neurogastroenterology and Motility 2019
Open access · CC-BY
Brain-Gut-Microbiota Axis in Alzheimer’s Disease
Interdisciplinary topics in gerontology and geriatrics 2013
Citation only
Chronic Mechanistic Target of Rapamycin Inhibition: Preventing Cancer to Delay Aging, or Vice Versa?
The Journals of Gerontology Series A 2016
Open access · CC-BY
Strategies and Challenges in Clinical Trials Targeting Human Aging
Frontiers in Cardiovascular Medicine 2021
Open access · CC-BY